CRSP
Crispr Therapeutics Ag Earnings
$40.72
Earnings Summary
Revenue | $0.6Mn |
Net Profits | $-85.94Mn |
Net Profit Margins | -14276.08% |
Crispr Therapeutics Ag’s revenue jumped +Inf% since last year same period to $0.6Mn in the Q3 2024. On a quarterly growth basis, Crispr Therapeutics Ag has generated 16.44% jump in its revenue since last 3-months.
Crispr Therapeutics Ag’s net profit jumped 23.37% since last year same period to $-85.94Mn in the Q3 2024. On a quarterly growth basis, Crispr Therapeutics Ag has generated 32.01% jump in its net profits since last 3-months.
Crispr Therapeutics Ag’s net profit margin jumped NaN% since last year same period to -14276.08% in the Q3 2024. On a quarterly growth basis, Crispr Therapeutics Ag has generated 41.61% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Crispr Therapeutics Ag post its latest quarter earningsEPS Estimate Current Quarter | -1.42 |
EPS Estimate Current Year | -1.42 |
Crispr Therapeutics Ag’s earning per share (EPS) estimates for the current quarter stand at -1.42 - a 6.58% jump from last quarter’s estimates.
Crispr Therapeutics Ag’s earning per share (EPS) estimates for the current year stand at -1.42.
Key Ratios
Key ratios of the Crispr Therapeutics Ag post its Q3 2024 earningsEarning Per Share (EPS) | -1.01 |
Crispr Therapeutics Ag’s earning per share (EPS) jumped 28.37% since last year same period to -1.01 in the Q3 2024. This indicates that the Crispr Therapeutics Ag has generated 28.37% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-05 | -1.52 | -1.49 | 1.97% |
2024-05-08 | -1.33 | -1.43 | -7.52% |
2024-11-05 | -1.42 | -1.01 | 28.87% |
₹0 US Stocks a/c Opening Fee